Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Completed
NCT Number: NCT01509287
Metabolic Screening in Patients With Donnai-Barrow Syndrome
This study focuses on the genetics and metabolism of Donnai-Barrow Syndrome (DBS).
Completed
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
The purpose of this study is to better understand the role of certain nutrients and vitamins in promoting the healthy development of individuals with Donnai-Barrow Syndrome. The investigators hope that the information gained by studying the metabolism of children with Donnai-Barrow Syndrome and their family members will lead to significant advances in the treatment of this disease.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All individuals affected with Donnai-Barrow Syndrome
Treatment and study plan
Primary outcomes
-
measures of blood sugar, cholesterol, vitamins A and D, and other compounds
Time frame: 5 years
Sponsors and collaborators
Lead sponsor
Massachusetts General Hospital
Other
Registry information
Important dates
- Study start
- 2010
- Primary completion
- 2022
- Study completion
- 2022
- First posted
- Jan 12, 2012
- Registry last updated
- Nov 22, 2022
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.